Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Irritable Bowel Syndrome Drug Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 IBS-D Drugs
1.2.3 IBS-C Drugs
1.2.4 Others
1.3 Market by Application
1.3.1 Global Irritable Bowel Syndrome Drug Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Women
1.3.3 Men
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Irritable Bowel Syndrome Drug Market Perspective (2018-2029)
2.2 Irritable Bowel Syndrome Drug Growth Trends by Region
2.2.1 Global Irritable Bowel Syndrome Drug Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Irritable Bowel Syndrome Drug Historic Market Size by Region (2018-2024)
2.2.3 Irritable Bowel Syndrome Drug Forecasted Market Size by Region (2024-2029)
2.3 Irritable Bowel Syndrome Drug Market Dynamics
2.3.1 Irritable Bowel Syndrome Drug Industry Trends
2.3.2 Irritable Bowel Syndrome Drug Market Drivers
2.3.3 Irritable Bowel Syndrome Drug Market Challenges
2.3.4 Irritable Bowel Syndrome Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Irritable Bowel Syndrome Drug Players by Revenue
3.1.1 Global Top Irritable Bowel Syndrome Drug Players by Revenue (2018-2024)
3.1.2 Global Irritable Bowel Syndrome Drug Revenue Market Share by Players (2018-2024)
3.2 Global Irritable Bowel Syndrome Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Irritable Bowel Syndrome Drug Revenue
3.4 Global Irritable Bowel Syndrome Drug Market Concentration Ratio
3.4.1 Global Irritable Bowel Syndrome Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Irritable Bowel Syndrome Drug Revenue in 2022
3.5 Irritable Bowel Syndrome Drug Key Players Head office and Area Served
3.6 Key Players Irritable Bowel Syndrome Drug Product Solution and Service
3.7 Date of Enter into Irritable Bowel Syndrome Drug Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Irritable Bowel Syndrome Drug Breakdown Data by Type
4.1 Global Irritable Bowel Syndrome Drug Historic Market Size by Type (2018-2024)
4.2 Global Irritable Bowel Syndrome Drug Forecasted Market Size by Type (2024-2029)
5 Irritable Bowel Syndrome Drug Breakdown Data by Application
5.1 Global Irritable Bowel Syndrome Drug Historic Market Size by Application (2018-2024)
5.2 Global Irritable Bowel Syndrome Drug Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Irritable Bowel Syndrome Drug Market Size (2018-2029)
6.2 North America Irritable Bowel Syndrome Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Irritable Bowel Syndrome Drug Market Size by Country (2018-2024)
6.4 North America Irritable Bowel Syndrome Drug Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Irritable Bowel Syndrome Drug Market Size (2018-2029)
7.2 Europe Irritable Bowel Syndrome Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Irritable Bowel Syndrome Drug Market Size by Country (2018-2024)
7.4 Europe Irritable Bowel Syndrome Drug Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Irritable Bowel Syndrome Drug Market Size (2018-2029)
8.2 Asia-Pacific Irritable Bowel Syndrome Drug Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Irritable Bowel Syndrome Drug Market Size by Region (2018-2024)
8.4 Asia-Pacific Irritable Bowel Syndrome Drug Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Irritable Bowel Syndrome Drug Market Size (2018-2029)
9.2 Latin America Irritable Bowel Syndrome Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Irritable Bowel Syndrome Drug Market Size by Country (2018-2024)
9.4 Latin America Irritable Bowel Syndrome Drug Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Irritable Bowel Syndrome Drug Market Size (2018-2029)
10.2 Middle East & Africa Irritable Bowel Syndrome Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Irritable Bowel Syndrome Drug Market Size by Country (2018-2024)
10.4 Middle East & Africa Irritable Bowel Syndrome Drug Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Ironwood Pharmaceuticals
11.1.1 Ironwood Pharmaceuticals Company Detail
11.1.2 Ironwood Pharmaceuticals Business Overview
11.1.3 Ironwood Pharmaceuticals Irritable Bowel Syndrome Drug Introduction
11.1.4 Ironwood Pharmaceuticals Revenue in Irritable Bowel Syndrome Drug Business (2018-2024)
11.1.5 Ironwood Pharmaceuticals Recent Development
11.2 Bausch Health
11.2.1 Bausch Health Company Detail
11.2.2 Bausch Health Business Overview
11.2.3 Bausch Health Irritable Bowel Syndrome Drug Introduction
11.2.4 Bausch Health Revenue in Irritable Bowel Syndrome Drug Business (2018-2024)
11.2.5 Bausch Health Recent Development
11.3 Takeda
11.3.1 Takeda Company Detail
11.3.2 Takeda Business Overview
11.3.3 Takeda Irritable Bowel Syndrome Drug Introduction
11.3.4 Takeda Revenue in Irritable Bowel Syndrome Drug Business (2018-2024)
11.3.5 Takeda Recent Development
11.4 Sebela Pharmaceuticals
11.4.1 Sebela Pharmaceuticals Company Detail
11.4.2 Sebela Pharmaceuticals Business Overview
11.4.3 Sebela Pharmaceuticals Irritable Bowel Syndrome Drug Introduction
11.4.4 Sebela Pharmaceuticals Revenue in Irritable Bowel Syndrome Drug Business (2018-2024)
11.4.5 Sebela Pharmaceuticals Recent Development
11.5 Allergan
11.5.1 Allergan Company Detail
11.5.2 Allergan Business Overview
11.5.3 Allergan Irritable Bowel Syndrome Drug Introduction
11.5.4 Allergan Revenue in Irritable Bowel Syndrome Drug Business (2018-2024)
11.5.5 Allergan Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Irritable Bowel Syndrome Drug Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of IBS-D Drugs
Table 3. Key Players of IBS-C Drugs
Table 4. Key Players of Others
Table 5. Global Irritable Bowel Syndrome Drug Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Irritable Bowel Syndrome Drug Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 7. Global Irritable Bowel Syndrome Drug Market Size by Region (2018-2024) & (US$ Million)
Table 8. Global Irritable Bowel Syndrome Drug Market Share by Region (2018-2024)
Table 9. Global Irritable Bowel Syndrome Drug Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 10. Global Irritable Bowel Syndrome Drug Market Share by Region (2024-2029)
Table 11. Irritable Bowel Syndrome Drug Market Trends
Table 12. Irritable Bowel Syndrome Drug Market Drivers
Table 13. Irritable Bowel Syndrome Drug Market Challenges
Table 14. Irritable Bowel Syndrome Drug Market Restraints
Table 15. Global Irritable Bowel Syndrome Drug Revenue by Players (2018-2024) & (US$ Million)
Table 16. Global Irritable Bowel Syndrome Drug Market Share by Players (2018-2024)
Table 17. Global Top Irritable Bowel Syndrome Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Irritable Bowel Syndrome Drug as of 2022)
Table 18. Ranking of Global Top Irritable Bowel Syndrome Drug Companies by Revenue (US$ Million) in 2022
Table 19. Global 5 Largest Players Market Share by Irritable Bowel Syndrome Drug Revenue (CR5 and HHI) & (2018-2024)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Irritable Bowel Syndrome Drug Product Solution and Service
Table 22. Date of Enter into Irritable Bowel Syndrome Drug Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Irritable Bowel Syndrome Drug Market Size by Type (2018-2024) & (US$ Million)
Table 25. Global Irritable Bowel Syndrome Drug Revenue Market Share by Type (2018-2024)
Table 26. Global Irritable Bowel Syndrome Drug Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 27. Global Irritable Bowel Syndrome Drug Revenue Market Share by Type (2024-2029)
Table 28. Global Irritable Bowel Syndrome Drug Market Size by Application (2018-2024) & (US$ Million)
Table 29. Global Irritable Bowel Syndrome Drug Revenue Market Share by Application (2018-2024)
Table 30. Global Irritable Bowel Syndrome Drug Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 31. Global Irritable Bowel Syndrome Drug Revenue Market Share by Application (2024-2029)
Table 32. North America Irritable Bowel Syndrome Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 33. North America Irritable Bowel Syndrome Drug Market Size by Country (2018-2024) & (US$ Million)
Table 34. North America Irritable Bowel Syndrome Drug Market Size by Country (2024-2029) & (US$ Million)
Table 35. Europe Irritable Bowel Syndrome Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 36. Europe Irritable Bowel Syndrome Drug Market Size by Country (2018-2024) & (US$ Million)
Table 37. Europe Irritable Bowel Syndrome Drug Market Size by Country (2024-2029) & (US$ Million)
Table 38. Asia-Pacific Irritable Bowel Syndrome Drug Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 39. Asia-Pacific Irritable Bowel Syndrome Drug Market Size by Region (2018-2024) & (US$ Million)
Table 40. Asia-Pacific Irritable Bowel Syndrome Drug Market Size by Region (2024-2029) & (US$ Million)
Table 41. Latin America Irritable Bowel Syndrome Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 42. Latin America Irritable Bowel Syndrome Drug Market Size by Country (2018-2024) & (US$ Million)
Table 43. Latin America Irritable Bowel Syndrome Drug Market Size by Country (2024-2029) & (US$ Million)
Table 44. Middle East & Africa Irritable Bowel Syndrome Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 45. Middle East & Africa Irritable Bowel Syndrome Drug Market Size by Country (2018-2024) & (US$ Million)
Table 46. Middle East & Africa Irritable Bowel Syndrome Drug Market Size by Country (2024-2029) & (US$ Million)
Table 47. Ironwood Pharmaceuticals Company Detail
Table 48. Ironwood Pharmaceuticals Business Overview
Table 49. Ironwood Pharmaceuticals Irritable Bowel Syndrome Drug Product
Table 50. Ironwood Pharmaceuticals Revenue in Irritable Bowel Syndrome Drug Business (2018-2024) & (US$ Million)
Table 51. Ironwood Pharmaceuticals Recent Development
Table 52. Bausch Health Company Detail
Table 53. Bausch Health Business Overview
Table 54. Bausch Health Irritable Bowel Syndrome Drug Product
Table 55. Bausch Health Revenue in Irritable Bowel Syndrome Drug Business (2018-2024) & (US$ Million)
Table 56. Bausch Health Recent Development
Table 57. Takeda Company Detail
Table 58. Takeda Business Overview
Table 59. Takeda Irritable Bowel Syndrome Drug Product
Table 60. Takeda Revenue in Irritable Bowel Syndrome Drug Business (2018-2024) & (US$ Million)
Table 61. Takeda Recent Development
Table 62. Sebela Pharmaceuticals Company Detail
Table 63. Sebela Pharmaceuticals Business Overview
Table 64. Sebela Pharmaceuticals Irritable Bowel Syndrome Drug Product
Table 65. Sebela Pharmaceuticals Revenue in Irritable Bowel Syndrome Drug Business (2018-2024) & (US$ Million)
Table 66. Sebela Pharmaceuticals Recent Development
Table 67. Allergan Company Detail
Table 68. Allergan Business Overview
Table 69. Allergan Irritable Bowel Syndrome Drug Product
Table 70. Allergan Revenue in Irritable Bowel Syndrome Drug Business (2018-2024) & (US$ Million)
Table 71. Allergan Recent Development
Table 72. Research Programs/Design for This Report
Table 73. Key Data Information from Secondary Sources
Table 74. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Irritable Bowel Syndrome Drug Market Size Comparison by Type (2024-2034) & (US$ Million)
Figure 2. Global Irritable Bowel Syndrome Drug Market Share by Type: 2022 VS 2029
Figure 3. IBS-D Drugs Features
Figure 4. IBS-C Drugs Features
Figure 5. Others Features
Figure 6. Global Irritable Bowel Syndrome Drug Market Size Comparison by Application (2024-2034) & (US$ Million)
Figure 7. Global Irritable Bowel Syndrome Drug Market Share by Application: 2022 VS 2029
Figure 8. Women Case Studies
Figure 9. Men Case Studies
Figure 10. Irritable Bowel Syndrome Drug Report Years Considered
Figure 11. Global Irritable Bowel Syndrome Drug Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 12. Global Irritable Bowel Syndrome Drug Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Irritable Bowel Syndrome Drug Market Share by Region: 2022 VS 2029
Figure 14. Global Irritable Bowel Syndrome Drug Market Share by Players in 2022
Figure 15. Global Top Irritable Bowel Syndrome Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Irritable Bowel Syndrome Drug as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Irritable Bowel Syndrome Drug Revenue in 2022
Figure 17. North America Irritable Bowel Syndrome Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 18. North America Irritable Bowel Syndrome Drug Market Share by Country (2018-2029)
Figure 19. United States Irritable Bowel Syndrome Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. Canada Irritable Bowel Syndrome Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. Europe Irritable Bowel Syndrome Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Europe Irritable Bowel Syndrome Drug Market Share by Country (2018-2029)
Figure 23. Germany Irritable Bowel Syndrome Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. France Irritable Bowel Syndrome Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. U.K. Irritable Bowel Syndrome Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Italy Irritable Bowel Syndrome Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Russia Irritable Bowel Syndrome Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Nordic Countries Irritable Bowel Syndrome Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Asia-Pacific Irritable Bowel Syndrome Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Asia-Pacific Irritable Bowel Syndrome Drug Market Share by Region (2018-2029)
Figure 31. China Irritable Bowel Syndrome Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Japan Irritable Bowel Syndrome Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. South Korea Irritable Bowel Syndrome Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Southeast Asia Irritable Bowel Syndrome Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. India Irritable Bowel Syndrome Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Australia Irritable Bowel Syndrome Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Latin America Irritable Bowel Syndrome Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Latin America Irritable Bowel Syndrome Drug Market Share by Country (2018-2029)
Figure 39. Mexico Irritable Bowel Syndrome Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Brazil Irritable Bowel Syndrome Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Middle East & Africa Irritable Bowel Syndrome Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Middle East & Africa Irritable Bowel Syndrome Drug Market Share by Country (2018-2029)
Figure 43. Turkey Irritable Bowel Syndrome Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Saudi Arabia Irritable Bowel Syndrome Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Ironwood Pharmaceuticals Revenue Growth Rate in Irritable Bowel Syndrome Drug Business (2018-2024)
Figure 46. Bausch Health Revenue Growth Rate in Irritable Bowel Syndrome Drug Business (2018-2024)
Figure 47. Takeda Revenue Growth Rate in Irritable Bowel Syndrome Drug Business (2018-2024)
Figure 48. Sebela Pharmaceuticals Revenue Growth Rate in Irritable Bowel Syndrome Drug Business (2018-2024)
Figure 49. Allergan Revenue Growth Rate in Irritable Bowel Syndrome Drug Business (2018-2024)
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed